In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination. (Q37218996)
scientific article published on September 1987
Language:
Current Data About In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.
(P31) (Q13442814)
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P50) (Q120908182)
(P1545) 1
(P1932) Jones RN
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(Q120908249)
(P1545) 2
(P1932) Barry AL
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(Q120908442)
(P1545) 5
(P1932) Thornsberry C
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P304) 1725-1729
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P407) (Q1860)

(P433) 9
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P478) 25
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P577) Tuesday, September 1, 1987
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P1433) (Q4041880)
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P1476) "In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination" (language: en)
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P2093) Packer RR
(P1545) 3
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

Gregory WW
(P1545) 4
(P248)
(P932) 269316
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3498740%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, September 27, 2019

(P2860) (Q35761805)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Wednesday, September 6, 2017

(Q35716328)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Wednesday, September 6, 2017

(Q28259678)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Wednesday, September 6, 2017

(Q35575783)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Wednesday, September 6, 2017

(Q39497703)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Wednesday, September 6, 2017

(Q40282197)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Thursday, September 14, 2017

(Q40219455)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Thursday, September 14, 2017

(Q39855431)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Thursday, September 14, 2017

(Q39834956)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Thursday, September 14, 2017

(Q40619146)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Thursday, September 14, 2017

(Q45048553)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Tuesday, June 26, 2018

(Q54443909)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269316
(P813) Tuesday, June 26, 2018

(Q64936774)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/3498740
(P813) Saturday, December 12, 2020
(P887)

(Q72906287)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/3498740
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article published on September 1987

External Links
(P356) 10.1128/JCM.25.9.1725-1729.1987
(P698) 3498740
(P932) 269316